tiprankstipranks
PCI Biotech Holding ASA (DE:4QG)
FRANKFURT:4QG
Germany Market
4QG
PCI Biotech Holding ASA
RESEARCH TOOLSreports

PCI Biotech Holding ASA (4QG) Income Statement

1 Followers

PCI Biotech Holding ASA Income Statement

Last quarter (Q2 2025), PCI Biotech Holding ASA's total revenue was kr689.50K, a decrease of -59.75% from the same quarter last year. In Q2, PCI Biotech Holding ASA's net income was kr-5.76M. See PCI Biotech Holding ASA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 6.74Mkr 2.99Mkr 4.75Mkr 6.27Mkr 7.37M
Gross Profit
kr 6.74Mkr 2.99Mkr -633.00Kkr -2.54Mkr 7.37M
Operating Expenses
kr 24.69Mkr 25.23Mkr 60.56Mkr 89.76Mkr 87.28M
Depreciation and Amortization
kr 303.00Kkr 19.00Kkr 633.00Kkr 2.54Mkr 2.21M
EBITDA
kr -17.65Mkr -22.22Mkr -54.10Mkr -82.70Mkr -69.12M
Operating Income
kr -17.95Mkr -22.24Mkr -56.45Mkr -86.03Mkr -82.12M
Other Income/Expenses
kr 1.54Mkr 1.93Mkr 1.35Mkr -2.36Mkr 9.88M
Pretax Income
kr -16.42Mkr -20.32Mkr -55.09Mkr -88.39Mkr -72.24M
Net Income
kr -16.42Mkr -20.32Mkr -55.09Mkr -88.48Mkr -72.24M
Per Share Metrics
Basic EPS
kr -0.44kr -0.54kr -1.48kr -2.37kr -1.94
Diluted EPS
kr -0.44kr -0.54kr -1.48kr -2.37kr -1.94
Weighted Average Shares Outstanding
 37.31M 37.33M 37.33M 37.33M 37.28M
Weighted Average Shares Outstanding (Diluted)
 37.31M 37.33M 37.33M 37.33M 37.28M
Currency in NOK

PCI Biotech Holding ASA Earnings and Revenue History